Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Edward Aldrich is active.

Publication


Featured researches published by Paul Edward Aldrich.


Biochemical and Biophysical Research Communications | 1990

[3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.

Andrew T. Chiu; Dale E. McCall; Paul Edward Aldrich; Pieter B.M.W.M. Timmermans

[3H]Dup 753, a nonpeptide angiotensin II (AII) receptor antagonist radioligand, was used to characterize a subtype of AII receptors in rat adrenal cortical microsomes. By Scatchard analysis, a single class of DuP 753 binding sites was found with an affinity of 6.4 nM and a Bmax of 1.3 pmol/mg protein. These sites were saturable and readily reversible. Angiotensin (I, II, III) expressed the same affinities and order of potency for these binding sites as those labeled by [3H]AII for the AII-1 sites. The affinities expressed by nonpeptide AII antagonists were commensurate with their inhibitory potencies on AII-1 receptors. PD123177, an AII-2 specific ligand, and other non-AII peptides showed no inhibitory action. These data together with the differential tissue distribution strongly support our conclusion that [3H]DuP 753 is a potent and highly specific radioligand for the AII-1 receptors.


Journal of Medicinal Chemistry | 1991

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

David John Carini; John Jonas Vytautas Duncia; Paul Edward Aldrich; Andrew T. Chiu; Alexander L. Johnson; Michael E. Pierce; William A. Price; Joseph Basil Santella; Gregory J. Wells


Archive | 1988

Tetrazole intermediates to antihypertensive compounds

Paul Edward Aldrich; John Jonas Vytautas Duncia; Michael E. Pierce


Journal of Medicinal Chemistry | 1971

Antiviral agents. 2. Structure-activity relationships of compounds related to 1-adamantanamine.

Paul Edward Aldrich; Edward C. Hermann; Walter E. Meier; Marvin Paulshock; William W. Prichard; Jack Austin Synder; John Conway Watts


Archive | 1975

1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Paul Edward Aldrich; Gilbert H. Berezin; Bruce Ivor Dittmar


Archive | 1991

Negative photoresists containing aminoacrylate salts

Paul Edward Aldrich; Philip Manos; Allan E. Nader


Archive | 1987

2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1-antagonist activity

Paul Edward Aldrich; Richard Alan Earl; Philip Ma


Archive | 1977

Antihypertensive polyfluorohydroxyisopropyl bicyclic and tricyclic carbostyrils

Paul Edward Aldrich; Gilbert H. Berezin


Archive | 1976

Antihypertensive hexafluorohydroxyisopropyl benzazepines and benzazocines

Paul Edward Aldrich; Gilbert H. Berezin


Archive | 1977

Polyfluorohydroxyisopropyl-heterocyclic compounds

Paul Edward Aldrich; Gilbert H. Berezin

Collaboration


Dive into the Paul Edward Aldrich's collaboration.

Researchain Logo
Decentralizing Knowledge